Table 2 Prevalence of known risk factors for COVID-19 among adult patients with recent diagnosis of SUD (and its subtypes) (“Y”) versus adult patients without recent diagnosis of SUD (and its subtypes) (“N”).

From: COVID-19 risk and outcomes in patients with substance use disorders: analyses from electronic health records in the United States

 

Asthma

(%)

CKD

COPD

(%)

T2D

(%)

CLD

(%)

CVD

(%)

HP

(%)

Obesity

(%)

HIV

Cancer

(%)

SUD

 Y

22.11

6.25

18.86

18.60

8.26

72.67

48.99

30.12

1.75

15.06

 N

6.89

1.03

1.63

4.64

1.20

23.34

13.02

7.23

0.27

3.83

AUD

 Y

17.86

5.77

16.86

14.91

12.61

73.61

53.77

21.38

2.35

14.41

 N

7.05

1.09

1.80

4.79

1.27

23.83

13.37

7.47

0.29

3.95

Cocaine-UD

 Y

25.77

10.09

22.03

20.73

16.34

75.45

51.33

25.56

4.90

10.37

 N

7.06

1.09

1.82

4.80

1.28

23.89

13.42

7.49

0.29

3.96

CUD

 Y

23.89

5.32

11.23

11.98

5.32

61.65

34.41

23.60

2.36

9.18

 N

7.05

1.09

1.82

4.80

1.09

23.89

13.42

7.49

0.29

3.96

OUD

 Y

23.93

7.60

17.63

17.44

7.60

71.49

46.35

26.75

1.70

15.98

 N

7.05

1.09

1.81

4.79

1.09

23.87

13.40

7.48

0.28

3.85

TUD

 Y

23.16

6.56

21.13

19.93

7.891

74.89

50.89

32.37

1.70

15.98

 N

6.91

1.04

1.64

4.66

1.22

23.42

13.07

7.26

0.28

3.85

  1. CKD chronic kidney disease, COPD chronic obstructive pulmonary disease, T2D diabetes mellitus type 2, CLD chronic liver disease, CVD cardiovascular diseases, HP hypertension.
Back to article page